from GEN News Highlights Intrexon Buys Stem Cell Tech Developer Medistem for $26M Intrexon said today it will acquire Medistem for $26 million, in a deal that will integrate the acquired company’s endometrial regenerative cells (ERCs) and the acquirer’s integrated ...
Read More »